Wolverine Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Wolverine Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,076	Closed	-$300K	–	2400
2022 Q4	$300K	Buy	+20,076	New	+$278K	﹤0.01%	1054

Wolverine Asset Management's AVEO Position: Q1 2023 in Review

Wolverine Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 20,076 shares — an estimated $300K sold.

Wolverine Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $300K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Wolverine Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 20,076 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $300K.
Wolverine Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Wolverine Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $300K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.